A standing thread for news that changes what is known or what is allowed: trial results, approval filings, regulator announcements and compounding rules.
When you post
- Link the primary source where you can: the regulator’s notice, the company’s release, the trial registration or the paper. Add news coverage as a second link.
- Say in one or two lines what changed.
- Mark rumours and unconfirmed reports as such.
Where the site tracks this
- US compounding status for each peptide
- Clinical trials: registered, recruiting and completed trials by peptide
- Peptide research: evidence grades and paper summaries
If a news item means one of those pages is out of date, say so here and we will update it.
The Community Rules apply: research discussion only, no dosing or personal-use advice, no buying, selling or sourcing requests, and disclose any vendor connection.